Porton Pharmasolutions Denmark ApS: Financial statements 2022
CVR: 43082671
Source: annual report 2022, Danish Business Authority
18/02/2022 – 31/12/2022
Porton Pharmasolutions Denmark ApS (CVR 43082671) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -958,543 and a net result of DKK -3,068,330. Equity in the 2022 report amounted to DKK 931,670. The solvency ratio was 44%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -958,543
- Profit/Loss
- DKK -3,068,330
- Equity
- DKK 931,670
- Total Assets
- DKK 2,115,340
- Employees
- 1
Official annual report
Keep an eye on Porton Pharmasolutions Denmark ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of February 18, 2022, Pavlos Kouroupis is registered as director of Porton Pharmasolutions Denmark ApS.
As of February 18, 2022, is registered as an owner of Porton Pharmasolutions Denmark ApS with an ownership share of 100%.
Porton Pharmasolutions Denmark ApS was founded on February 18, 2022.
About Porton Pharmasolutions Denmark ApS
Porton Pharmasolutions Denmark ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2022. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Pavlos Kouroupis. The company is owned by Porton Pharmaceutical Chemicals GmbH. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 2,705,608 and a net result of DKK 94,702 compared with DKK -1,682,051 the year before. Equity in the 2025 report amounted to DKK -3,983,464.